{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:10:58Z","timestamp":1790172658466,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1019-3","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T10:04:20Z","timestamp":1550052260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-8658","authenticated-orcid":false,"given":"Adrien","family":"Ben Hamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ladsous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Loyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Moerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Boury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00e9va","family":"Kyheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire-Marie","family":"Dhaenens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Tiffreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lebuffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Caiazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-0463","authenticated-orcid":false,"given":"Marie Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"issue":"10","key":"1019_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neurol.2016.08.003","volume":"172","author":"M Antonio De","year":"2016","unstructured":"De Antonio M, Dogan C, Hamroun D, Mati M, Zerrouki S, Eymard B, et al. Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification. Rev Neurol (Paris). 2016;172(10):572\u201380.","journal-title":"Rev Neurol (Paris)"},{"key":"1019_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fncel.2017.00101","volume":"11","author":"G Gourdon","year":"2017","unstructured":"Gourdon G, Meola G. Myotonic dystrophies: state of the art of new therapeutic developments for the CNS. Front Cell Neurosci. 2017;11:101.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1019_CR3","doi-asserted-by":"publisher","first-page":"e0148264","DOI":"10.1371\/journal.pone.0148264","volume":"11","author":"C Dogan","year":"2016","unstructured":"Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, et al. Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a Nationwide multiple databases cross-sectional observational study. PLoS One. 2016;11(2):e0148264.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"1019_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jns.2013.06.008","volume":"331","author":"E Passeri","year":"2013","unstructured":"Passeri E, Bugiardini E, Sansone VA, Valaperta R, Costa E, Ambrosi B, et al. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies. J Neurol Sci. 2013;331(1\u20132):132\u20135.","journal-title":"J Neurol Sci"},{"issue":"5","key":"1019_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00415-011-6277-5","volume":"259","author":"MC \u00d8rngreen","year":"2012","unstructured":"\u00d8rngreen MC, Arlien-S\u00f8borg P, Duno M, Hertz JM, Vissing J. Endocrine function in 97 patients with myotonic dystrophy type 1. J Neurol. 2012;259(5):912\u201320.","journal-title":"J Neurol"},{"issue":"4","key":"1019_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/mus.25145","volume":"54","author":"D Abbott","year":"2016","unstructured":"Abbott D, Johnson NE, Cannon-Albright LA. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy. Muscle Nerve. 2016;54(4):783\u20135.","journal-title":"Muscle Nerve"},{"issue":"3","key":"1019_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s00415-015-8006-y","volume":"263","author":"MLE Bianchi","year":"2016","unstructured":"Bianchi MLE, Leoncini E, Masciullo M, Modoni A, Gadalla SM, Massa R, et al. Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors. J Neurol. 2016;263(3):492\u20138.","journal-title":"J Neurol"},{"issue":"12","key":"1019_CR8","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000003124","volume":"87","author":"R Fern\u00e1ndez-Torr\u00f3n","year":"2016","unstructured":"Fern\u00e1ndez-Torr\u00f3n R, Garc\u00eda-Puga M, Emparanza J-I, Maneiro M, Cobo A-M, Poza J-J, et al. Cancer risk in DM1 is sex-related and linked to miRNA-200\/141 downregulation. Neurology 20. 2016;87(12):1250\u20137.","journal-title":"Neurology 20"},{"issue":"3","key":"1019_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/ene.12886","volume":"23","author":"SM Gadalla","year":"2016","unstructured":"Gadalla SM, Pfeiffer RM, Kristinsson SY, Bj\u00f6rkholm M, Landgren O, Greene MH. Brain tumors in patients with myotonic dystrophy: a population-based study. Eur J Neurol. 2016;23(3):542\u20137.","journal-title":"Eur J Neurol"},{"issue":"10","key":"1019_CR10","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00415-012-6476-8","volume":"259","author":"M Das","year":"2012","unstructured":"Das M, Moxley RT, Hilbert JE, Martens WB, Letren L, Greene MH, et al. Correlates of tumor development in patients with myotonic dystrophy. J Neurol. 2012;259(10):2161\u20136.","journal-title":"J Neurol"},{"issue":"6","key":"1019_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/ijc.31143","volume":"142","author":"Y Wang","year":"2017","unstructured":"Wang Y, Pfeiffer RM, Alsaggaf R, Meeraus W, Gage JC, Anderson LA, et al. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. clinical practice research datalink. Int J Cancer. 2017;142(6):1174\u201381.","journal-title":"Int J Cancer"},{"issue":"4","key":"1019_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/mus.26194","volume":"58","author":"JI Emparanza","year":"2018","unstructured":"Emparanza JI, L\u00f3pez de Munain A, Greene MH, Matheu A, Fern\u00e1ndez-Torr\u00f3n R, Gadalla SM. Cancer phenotype in myotonic dystrophy patients: results from a meta-analysis. Muscle Nerve. 2018;58(4):517\u201322.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1019_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.mayocp.2011.09.005","volume":"87","author":"AK Win","year":"2012","unstructured":"Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM. Increased cancer risks in myotonic dystrophy. Mayo Clin Proc. 2012;87(2):130\u20135.","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"1019_CR14","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1001\/jama.2011.1796","volume":"306","author":"SM Gadalla","year":"2011","unstructured":"Gadalla SM, Lund M, Pfeiffer RM, G\u00f8rtz S, Mueller CM, Moxley RT, et al. Cancer risk among patients with myotonic muscular dystrophy. JAMA. 2011;306(22):2480\u20136.","journal-title":"JAMA"},{"issue":"2","key":"1019_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/mus.25736","volume":"57","author":"R Alsaggaf","year":"2018","unstructured":"Alsaggaf R, Wang Y, Marini-Bettolo C, Wood L, Nikolenko N, Lochm\u00fcller H, et al. Benign and malignant tumors in the UK myotonic dystrophy patient registry. Muscle Nerve. 2018;57(2):316\u201320.","journal-title":"Muscle Nerve"},{"issue":"7\u20138","key":"1019_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jradio.2011.03.022","volume":"92","author":"G Russ","year":"2011","unstructured":"Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M. The thyroid imaging reporting and data system (TIRADS) for ultrasound of the thyroid. J Radiol. 2011;92(7\u20138):701\u201313.","journal-title":"J Radiol"},{"key":"1019_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8401518","volume":"2017","author":"D Dauksiene","year":"2017","unstructured":"Dauksiene D, Petkeviciene J, Klumbiene J, Verkauskiene R, Vainikonyte-Kristapone J, Seibokaite A, et al. Factors associated with the prevalence of thyroid nodules and goiter in middle-aged Euthyroid subjects. Int J Endocrinol. 2017;2017:8401518.","journal-title":"Int J Endocrinol"},{"issue":"30","key":"1019_CR18","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1200\/JCO.2016.67.7419","volume":"34","author":"L Furuya-Kanamori","year":"2016","unstructured":"Furuya-Kanamori L, Bell KJL, Clark J, Glasziou P, Doi SAR. Prevalence of differentiated thyroid Cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016;34(30):3672\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1019_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3346\/jkms.2014.29.5.676","volume":"29","author":"YS Lee","year":"2014","unstructured":"Lee YS, Lim H, Chang H-S, Park CS. Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy. J Korean Med Sci. 2014;29(5):676\u20139.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"1019_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4132\/jptm.2017.09.26","volume":"51","author":"YJ Cha","year":"2017","unstructured":"Cha YJ, Pyo JY, Hong S, Seok JY, Kim K-J, Han J-Y, et al. Thyroid fine-needle aspiration cytology practice in Korea. J Pathol Transl Med. 2017;51(6):521\u20137.","journal-title":"J Pathol Transl Med"},{"issue":"4","key":"1019_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/thy.2016.0628","volume":"27","author":"BR Haugen","year":"2017","unstructured":"Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, et al. American Thyroid Association guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):481\u20133.","journal-title":"Thyroid"},{"issue":"13","key":"1019_CR22","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid Cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338\u201348.","journal-title":"JAMA"},{"issue":"3","key":"1019_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","volume":"40","author":"A Miyauchi","year":"2016","unstructured":"Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2016;40(3):516\u201322.","journal-title":"World J Surg"},{"issue":"5","key":"1019_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archinte.160.5.661","volume":"160","author":"TH Brix","year":"2000","unstructured":"Brix TH, Hansen PS, Kyvik KO, Heged\u00fcs L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med. 2000;160(5):661\u20136.","journal-title":"Arch Intern Med"},{"issue":"7","key":"1019_CR25","first-page":"11379","volume":"8","author":"L Zheng","year":"2015","unstructured":"Zheng L, Yan W, Kong Y, Liang P, Mu Y. An epidemiological study of risk factors of thyroid nodule and goiter in Chinese women. Int J Clin Exp Med. 2015;8(7):11379\u201387.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1019_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1590\/S0004-27302013000200004","volume":"57","author":"PAM Sousa de","year":"2013","unstructured":"de Sousa PAM, Vaisman M, Carneiro JRI, Guimar\u00e3es L, Freitas H, Pinheiro MFC, et al. Prevalence of goiter and thyroid nodular disease in patients with class III obesity. Arq Bras Endocrinol Metabol. 2013;57(2):120\u20135.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"2","key":"1019_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2265.2007.02870.x","volume":"67","author":"MC Vantyghem","year":"2007","unstructured":"Vantyghem MC, Faivre-Defrance F, Marcelli-Tourvieille S, Fermon C, Evrard A, Bourdelle-Hego MF, et al. Familial partial lipodystrophy due to the LMNA R482W mutation with multinodular goitre, extrapyramidal syndrome and primary hyperaldosteronism. Clin Endocrinol. 2007;67(2):247\u20139.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1019_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/eje.0.1460397","volume":"146","author":"A Johansson","year":"2002","unstructured":"Johansson A, Olsson T, Cederquist K, Forsberg H, Holst JJ, Seckl JR, et al. Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy. Eur J Endocrinol. 2002;146(3):397\u2013405.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1019_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mus.24540","volume":"52","author":"M Vujnic","year":"2015","unstructured":"Vujnic M, Peric S, Popovic S, Raseta N, Ralic V, Dobricic V, et al. Metabolic syndrome in patients with myotonic dystrophy type 1. Muscle Nerve. 2015;52(2):273\u20137.","journal-title":"Muscle Nerve"},{"issue":"9","key":"1019_CR30","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1007\/s00415-013-6984-1","volume":"260","author":"C Terracciano","year":"2013","unstructured":"Terracciano C, Rastelli E, Morello M, Celi M, Bucci E, Antonini G, et al. Vitamin D deficiency in myotonic dystrophy type 1. J Neurol. 2013;260(9):2330\u20134.","journal-title":"J Neurol"},{"issue":"4","key":"1019_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S2213-8587(14)70225-6","volume":"3","author":"MB Zimmermann","year":"2015","unstructured":"Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3(4):286\u201395.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"39","key":"1019_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001639","volume":"94","author":"J Ma","year":"2015","unstructured":"Ma J, Wu D, Li C, Fan C, Chao N, Liu J, et al. Lower serum 25-Hydroxyvitamin D level is associated with 3 types of autoimmune thyroid diseases. Medicine (Baltimore). 2015;94(39):e1639.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1019_CR33","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ando.2015.01.003","volume":"76","author":"S Meng","year":"2015","unstructured":"Meng S, He S, Jiang W, Xiao L, Li D, Xu J, et al. Genetic susceptibility to autoimmune thyroid diseases in a Chinese Han population: role of vitamin D receptor gene polymorphisms. Ann Endocrinol (Paris). 2015;76(6):684\u20139.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"1019_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","volume":"96","author":"S Christakos","year":"2016","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365\u2013408.","journal-title":"Physiol Rev"},{"key":"1019_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jsbmb.2016.12.008","volume":"173","author":"A Mousa","year":"2017","unstructured":"Mousa A, Naderpoor N, de Courten MPJ, Scragg R, de Courten B. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight\/obese but otherwise healthy cohort. J Steroid Biochem Mol Biol 19. 2017;173:258\u201364.","journal-title":"J Steroid Biochem Mol Biol 19"},{"issue":"11","key":"1019_CR36","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/jmg.31.11.891","volume":"31","author":"C Daumerie","year":"1994","unstructured":"Daumerie C, Lannoy N, Squifflet JP, Verellen G, Verellen-Dumoulin C. High CTG repeat number in nodular thyroid tissue from a myotonic dystrophy patient. J Med Genet. 1994;31(11):891\u20132.","journal-title":"J Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1019-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1019-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1019-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:15:17Z","timestamp":1581534917000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1019-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1019-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Committee for the Protection of Person (CPP), IORG 0009553 \u2013 Institutional Review Board for the University Hospital of Lille.Ethical Committee under number: HP 1821 (BenHamou_Ethics_OJRD.pdf).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"42"}}